You are using an older browser version. Please use a supported version for the best MSN experience.

Covid drugs haven't been a major contributor to our revenue, says Indian pharmaceutical firm

Vinita Gupta of Lupin discusses what's in the company's pipeline.

UP NEXT

UP NEXT

More From CNBC

More From CNBC

CNBC

Fortune

image beaconimage beaconimage beacon